AdaptHealth (NASDAQ:AHCO) Price Target Raised to $14.00 at Royal Bank of Canada

AdaptHealth (NASDAQ:AHCO) had its price objective hoisted by Royal Bank of Canada from $11.00 to $14.00 in a research report report published on Wednesday,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Several other research firms have also recently commented on AHCO. UBS Group reduced their target price on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. Canaccord Genuity Group cut their price objective on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Robert W. Baird decreased their price objective on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 6th. Finally, Truist Financial lifted their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $13.40.

AdaptHealth Stock Up 4.3 %

Shares of NASDAQ:AHCO opened at $11.10 on Wednesday. The company has a market cap of $1.49 billion, a price-to-earnings ratio of -6.73, a PEG ratio of 1.08 and a beta of 1.12. AdaptHealth has a one year low of $8.35 and a one year high of $11.90. The firm has a fifty day moving average price of $9.87 and a two-hundred day moving average price of $10.21. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00.

Hedge Funds Weigh In On AdaptHealth

Several institutional investors have recently modified their holdings of the company. Louisiana State Employees Retirement System boosted its stake in AdaptHealth by 30.0% in the third quarter. Louisiana State Employees Retirement System now owns 51,100 shares of the company’s stock worth $574,000 after buying an additional 11,800 shares in the last quarter. State of Alaska Department of Revenue lifted its holdings in shares of AdaptHealth by 31.5% in the 3rd quarter. State of Alaska Department of Revenue now owns 60,304 shares of the company’s stock worth $677,000 after acquiring an additional 14,438 shares during the last quarter. Harbor Capital Advisors Inc. boosted its stake in shares of AdaptHealth by 142.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 449,840 shares of the company’s stock valued at $5,052,000 after purchasing an additional 264,610 shares in the last quarter. Amalgamated Bank grew its holdings in shares of AdaptHealth by 26.7% during the 3rd quarter. Amalgamated Bank now owns 30,916 shares of the company’s stock valued at $347,000 after purchasing an additional 6,524 shares during the last quarter. Finally, Principal Financial Group Inc. raised its position in AdaptHealth by 39.7% in the 3rd quarter. Principal Financial Group Inc. now owns 543,744 shares of the company’s stock worth $6,106,000 after purchasing an additional 154,434 shares during the period. 82.67% of the stock is currently owned by institutional investors.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.